[go: up one dir, main page]

AU2002234773A1 - Pharmaceutically effective ginsenosides and their use - Google Patents

Pharmaceutically effective ginsenosides and their use

Info

Publication number
AU2002234773A1
AU2002234773A1 AU2002234773A AU2002234773A AU2002234773A1 AU 2002234773 A1 AU2002234773 A1 AU 2002234773A1 AU 2002234773 A AU2002234773 A AU 2002234773A AU 2002234773 A AU2002234773 A AU 2002234773A AU 2002234773 A1 AU2002234773 A1 AU 2002234773A1
Authority
AU
Australia
Prior art keywords
pharmaceutically effective
ginsenosides
effective ginsenosides
pharmaceutically
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002234773A
Other languages
English (en)
Inventor
Tai-Ping Fan
Hi Wun Leung
Shiladitya Sengupta
Sue-Anne Ee Shiow Toh
Ngok Shun Ricky Wong
Hin Wing Yeung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd CUTS
Hong Kong Baptist University HKBU
Original Assignee
Cambridge University Technical Services Ltd CUTS
Hong Kong Baptist University HKBU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Technical Services Ltd CUTS, Hong Kong Baptist University HKBU filed Critical Cambridge University Technical Services Ltd CUTS
Publication of AU2002234773A1 publication Critical patent/AU2002234773A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002234773A 2001-03-07 2002-03-01 Pharmaceutically effective ginsenosides and their use Abandoned AU2002234773A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0105613.4A GB0105613D0 (en) 2001-03-07 2001-03-07 Pharmaceutically effective compounds and their use
GB0105613.4 2001-03-07
PCT/GB2002/000891 WO2002069980A2 (fr) 2001-03-07 2002-03-01 Composes pharmaceutiquement efficaces et utilisation de ces composes

Publications (1)

Publication Number Publication Date
AU2002234773A1 true AU2002234773A1 (en) 2002-09-19

Family

ID=9910153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002234773A Abandoned AU2002234773A1 (en) 2001-03-07 2002-03-01 Pharmaceutically effective ginsenosides and their use

Country Status (3)

Country Link
AU (1) AU2002234773A1 (fr)
GB (1) GB0105613D0 (fr)
WO (1) WO2002069980A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136785A1 (en) * 2000-11-07 2002-09-26 Chun-Su Yuan Ginseng berry extracts and pharmaceutical compositions from ginseng berry for the treatment of type 2 diabetes and obesity
DE10158281A1 (de) * 2001-11-19 2003-05-28 Mediwirk Gmbh Pharmazeutisches Präparat
EA009442B1 (ru) 2003-06-23 2007-12-28 Герон Корпорейшн Композиции и способы увеличения активности теломеразы
US9248088B2 (en) 2003-06-25 2016-02-02 Telomerase Activation Sciences, Inc. Compositions and methods for skin conditioning
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
CN102391345B (zh) * 2011-10-25 2012-10-31 吉林大学 一种拟人参皂苷-Rh2及在制备治疗肿瘤药物的应用
KR102158201B1 (ko) 2017-04-07 2020-09-21 주식회사 세라젬 온열 치료기 및 그 제어 방법
CN112898371B (zh) * 2021-03-20 2022-03-29 延边大学 一类人参三醇类化合物及其制备方法和医用用途
CN115444612B (zh) * 2021-04-02 2025-11-25 苏州大学 一种倒刺蚕丝缝合线

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684628A (en) * 1985-05-03 1987-08-04 Yaguang Liu Pharmaceutical composition containing pure San-Mai-Sen
US4755504A (en) * 1985-10-03 1988-07-05 Yaguang Liu Pharmaceutical composition from Tienchi
GB9024895D0 (en) * 1990-11-15 1991-01-02 Erba Carlo Spa Therapeutic use of fibroblast growth factor
FR2695561B1 (fr) * 1992-09-17 1994-12-02 Lvmh Rech Gie Composition cosmétique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux.
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
JPH1036388A (ja) * 1996-07-25 1998-02-10 Kureha Chem Ind Co Ltd ジンセノサイド類含有ｈｓｐ４７合成抑制剤
JP2000191539A (ja) * 1998-12-22 2000-07-11 Japan Science & Technology Corp ジンセノサイドＲｂ１からなる脳細胞又は神経細胞保護剤
JP2000302798A (ja) * 1999-02-19 2000-10-31 Japan Science & Technology Corp ジンセノサイドＲｂ１からなる脳血管再生・再構築促進剤ならびに神経組織二次変性抑止剤
US7235267B1 (en) * 1999-08-30 2007-06-26 Japan Science And Technology Corporation Brain cell or nerve cell-protecting agents comprising medicinal ginseng
JP2002322068A (ja) * 2001-02-26 2002-11-08 Japan Science & Technology Corp 血管再生促進剤

Also Published As

Publication number Publication date
WO2002069980A2 (fr) 2002-09-12
WO2002069980A3 (fr) 2004-04-15
GB0105613D0 (en) 2001-04-25

Similar Documents

Publication Publication Date Title
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU3620600A (en) Skin-marking devices and their use
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2002315263A1 (en) Aluminium implant and use thereof
AU715620C (en) Therapeutic methods and uses
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002234773A1 (en) Pharmaceutically effective ginsenosides and their use
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2841801A (en) Triazolotriazinones and the use thereof
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001229439A1 (en) Bioconjugates and uses thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2669201A (en) Taccalonolides and their use
AU2001277519A1 (en) Bio-probes and use thereof
AU2001259564A1 (en) Pharmaceutical compositions and methods for use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase